BR0314284A - Compostos de imidazopiridina como agonistas do receptor 5-ht4 - Google Patents
Compostos de imidazopiridina como agonistas do receptor 5-ht4Info
- Publication number
- BR0314284A BR0314284A BR0314284-1A BR0314284A BR0314284A BR 0314284 A BR0314284 A BR 0314284A BR 0314284 A BR0314284 A BR 0314284A BR 0314284 A BR0314284 A BR 0314284A
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl group
- group
- carbon atoms
- compounds
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
"COMPOSTOS DE IMIDAZOPIRIDINA COMO AGONISTAS DO RECEPTOR 5-HT~ 4~". Esta invenção refere-se a um composto da fórmula (I): em que R^ 1^ representa um átomo de hidrogênio ou um átomo de halogênio; R^ 2^ representa um grupo metila ou um grupo etila; R^ 3^ representa um grupo alquila ramificado possuindo desde 3 até 6 átomos de carbono ou um grupo alquila possuindo desde 3 até 6 átomos de carbono substituídos com um grupo alcóxi possuindo desde 1 até 6 átomos de carbono; na condição de que quando o átomo de carbono terminal do referido grupo alquila está substituído com o referido grupo alcóxi, o referido grupo alquila é um grupo alquila ramificado; e seus sais farmaceuticamente aceitáveis. Estes compostos têm atividade de ligação ao receptor 5-HT~ 4~ e são, deste modo, úteis para o tratamento da doença do refluxo gastroesofágico, dispepsia não-ulcerosa, dispepsia funcional, síndrome do intestino irritável ou similares em mamíferos, especialmente seres humanos. Esta invenção proporciona também uma composição farmacêutica compreendendo o composto acima.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41248502P | 2002-09-20 | 2002-09-20 | |
PCT/IB2003/003971 WO2004026869A1 (en) | 2002-09-20 | 2003-09-08 | Imidazopyridine compunds as 5-ht4 receptor agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0314284A true BR0314284A (pt) | 2005-07-26 |
Family
ID=32030883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0314284-1A BR0314284A (pt) | 2002-09-20 | 2003-09-08 | Compostos de imidazopiridina como agonistas do receptor 5-ht4 |
Country Status (13)
Country | Link |
---|---|
US (1) | US7012080B2 (pt) |
EP (1) | EP1543005A1 (pt) |
JP (1) | JP2006502181A (pt) |
AR (1) | AR041302A1 (pt) |
AU (1) | AU2003263424A1 (pt) |
BR (1) | BR0314284A (pt) |
CA (1) | CA2497665A1 (pt) |
DO (1) | DOP2003000703A (pt) |
GT (1) | GT200300207A (pt) |
MX (1) | MXPA05001882A (pt) |
PA (1) | PA8581401A1 (pt) |
TW (1) | TW200424198A (pt) |
WO (1) | WO2004026869A1 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
EP1620435A1 (en) * | 2003-04-21 | 2006-02-01 | Pfizer Inc. | IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY AND 5-HT sb 3 /sb RECEPTOR ANTAGONISTIC ACTIVITY |
TW200533348A (en) * | 2004-02-18 | 2005-10-16 | Theravance Inc | Indazole-carboxamide compounds as 5-ht4 receptor agonists |
US8309575B2 (en) | 2004-04-07 | 2012-11-13 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
US7728006B2 (en) * | 2004-04-07 | 2010-06-01 | Theravance, Inc. | Quinolinone-carboxamide compounds as 5-HT4 receptor agonists |
TWI351282B (en) | 2004-04-07 | 2011-11-01 | Theravance Inc | Quinolinone-carboxamide compounds as 5-ht4 recepto |
WO2005118531A1 (en) * | 2004-06-01 | 2005-12-15 | Eli Lilly And Company | Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake |
CA2569654C (en) * | 2004-06-15 | 2010-12-21 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
US7737163B2 (en) * | 2004-06-15 | 2010-06-15 | Pfizer Inc. | Benzimidazolone carboxylic acid derivatives |
WO2006052640A1 (en) * | 2004-11-05 | 2006-05-18 | Theravance, Inc. | 5-ht4 receptor agonist compounds |
EP1807423B1 (en) * | 2004-11-05 | 2009-05-20 | Theravance, Inc. | Quinolinone-carboxamide compounds |
BRPI0519708A2 (pt) * | 2004-12-22 | 2009-03-10 | Theravance Inc | compostos de indazol-carboxamida |
CA2598536C (en) * | 2005-02-22 | 2011-04-05 | Pfizer Inc. | Oxyindole derivatives as 5ht4 receptor agonists |
KR20070107807A (ko) * | 2005-03-02 | 2007-11-07 | 세라밴스 인코포레이티드 | 5-ht4 수용체 아고니스트인 퀴놀리논 화합물 |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
AR080055A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1 |
WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
CN102753527B (zh) | 2010-02-02 | 2014-12-24 | 诺华股份有限公司 | 用作crf受体拮抗剂的环己基酰胺衍生物 |
AR086554A1 (es) | 2011-05-27 | 2014-01-08 | Novartis Ag | Derivados de la piperidina 3-espirociclica como agonistas de receptores de la ghrelina |
EP2852591A1 (en) | 2012-05-03 | 2015-04-01 | Novartis AG | L-malate salt of 2, 7 - diaza - spiro [4.5]dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
AU2015342887B2 (en) | 2014-11-06 | 2020-09-10 | Bial - R&D Investments, S.A. | Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders |
AU2015342883B2 (en) | 2014-11-06 | 2020-07-02 | Bial - R&D Investments, S.A. | Substituted pyrrolo(1,2-a)pyrimidines and their use in the treatment of medical disorders |
ES2958391T3 (es) | 2014-11-06 | 2024-02-08 | Bial R&D Invest S A | Imidazo[1,5-a]pirimidinas sustituidas y su uso en el tratamiento de trastornos médicos |
JP7034935B2 (ja) | 2016-04-06 | 2022-03-14 | リソソーマル・セラピューティクス・インコーポレイテッド | ピロロ[1,2-a]ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用 |
EP3440080A4 (en) | 2016-04-06 | 2020-01-22 | Lysosomal Therapeutics Inc. | PYRAZOLO [1,5-A] PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS |
MX2018012208A (es) | 2016-04-06 | 2019-03-28 | Lysosomal Therapeutics Inc | Compuestos a base de imidazo [1,5-a] pirimidinil carboxamida y su uso en el tratamiento de trastornos médicos. |
US11345698B2 (en) | 2016-05-05 | 2022-05-31 | Bial—R&D Investments, S.A. | Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders |
AU2017261291C1 (en) | 2016-05-05 | 2022-05-26 | Bial - R&D Investments, S.A. | Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4851423A (en) | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
JP2643274B2 (ja) | 1988-04-08 | 1997-08-20 | 三菱化学株式会社 | イミダゾ〔1,2−a〕ピリジン誘導体 |
US5219850A (en) * | 1991-03-07 | 1993-06-15 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
US5137893A (en) * | 1991-03-07 | 1992-08-11 | G. D. Searle & Co. | Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
US5196547A (en) * | 1991-03-07 | 1993-03-23 | G. D. Searle & Co. | Meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof |
US5260303A (en) * | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
GB9221468D0 (en) * | 1992-10-13 | 1992-11-25 | Smithkline Beecham Plc | Pharmaceuticals |
ZA948393B (en) * | 1993-11-01 | 1995-06-26 | Polartechnics Ltd | Method and apparatus for tissue type recognition |
WO1996005166A1 (fr) * | 1994-08-11 | 1996-02-22 | Yamanouchi Pharmaceutical Co., Ltd. | Derive d'amine substitue et composition medicamenteuse le contenant |
US5807272A (en) * | 1995-10-31 | 1998-09-15 | Worcester Polytechnic Institute | Impedance spectroscopy system for ischemia monitoring and detection |
WO1997027852A1 (en) | 1996-01-30 | 1997-08-07 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
CA2249601A1 (en) | 1996-04-03 | 1997-10-23 | Thorsten E. Fisher | Inhibitors of farnesyl-protein transferase |
WO1998033451A1 (en) * | 1997-02-04 | 1998-08-06 | National Aeronautics And Space Administration | Multimodality instrument for tissue characterization |
US6026323A (en) * | 1997-03-20 | 2000-02-15 | Polartechnics Limited | Tissue diagnostic system |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
EP1068185A1 (en) | 1998-03-31 | 2001-01-17 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
JP4032566B2 (ja) | 1999-06-21 | 2008-01-16 | 東レ株式会社 | 発光素子 |
US6624162B2 (en) * | 2001-10-22 | 2003-09-23 | Pfizer Inc. | Imidazopyridine compounds as 5-HT4 receptor modulators |
JP2005526003A (ja) * | 2001-10-22 | 2005-09-02 | ファイザー株式会社 | 5−ht4受容体調節剤としてのイミダゾピリジン化合物 |
-
2003
- 2003-08-29 DO DO2003000703A patent/DOP2003000703A/es unknown
- 2003-09-02 PA PA20038581401A patent/PA8581401A1/es unknown
- 2003-09-08 BR BR0314284-1A patent/BR0314284A/pt not_active IP Right Cessation
- 2003-09-08 MX MXPA05001882A patent/MXPA05001882A/es unknown
- 2003-09-08 AU AU2003263424A patent/AU2003263424A1/en not_active Abandoned
- 2003-09-08 EP EP03797457A patent/EP1543005A1/en not_active Withdrawn
- 2003-09-08 JP JP2004537414A patent/JP2006502181A/ja active Pending
- 2003-09-08 WO PCT/IB2003/003971 patent/WO2004026869A1/en not_active Application Discontinuation
- 2003-09-08 CA CA002497665A patent/CA2497665A1/en not_active Abandoned
- 2003-09-17 US US10/667,188 patent/US7012080B2/en not_active Expired - Fee Related
- 2003-09-18 AR ARP030103389A patent/AR041302A1/es unknown
- 2003-09-19 TW TW092125920A patent/TW200424198A/zh unknown
- 2003-09-19 GT GT200300207A patent/GT200300207A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PA8581401A1 (es) | 2004-05-26 |
DOP2003000703A (es) | 2004-03-31 |
TW200424198A (en) | 2004-11-16 |
US20040122043A1 (en) | 2004-06-24 |
GT200300207A (es) | 2004-04-29 |
AR041302A1 (es) | 2005-05-11 |
WO2004026869A1 (en) | 2004-04-01 |
US7012080B2 (en) | 2006-03-14 |
AU2003263424A1 (en) | 2004-04-08 |
CA2497665A1 (en) | 2004-04-01 |
EP1543005A1 (en) | 2005-06-22 |
JP2006502181A (ja) | 2006-01-19 |
MXPA05001882A (es) | 2005-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0314284A (pt) | Compostos de imidazopiridina como agonistas do receptor 5-ht4 | |
BRPI0409592A (pt) | compostos imidazopiridina tendo atividade agonìstica do receptor 5-ht4 e atividade antagonìstica do receptor 5-ht3 | |
BR0314584A (pt) | Compostos piperidinil-imidazopiridina n-substituìda como moduladores e receptores 5-ht4 | |
BR0300018A (pt) | Compostos oxo ou oxi-piridina como moduladores do receptor 5-ht4 | |
BRPI0507180A (pt) | derivados de 1-isopropil-2-oxo-1,2-diidropiridina-3-carboxamida tendo atividade agonìstica de receptor 5-ht4 | |
BR0111538A (pt) | Derivados de 1,3,8-triaza-espiro 4,5!decan-4-ona como antogonistas de receptor de neurocinina | |
BRPI0414130A (pt) | compostos de fenilamida ou piridilamida como antagonistas de prostaglandina e2 | |
BRPI0418082A (pt) | antagonista de receptor de adenosina a2a, agente para tratar e/ou prevenir doenças, composto, composição farmacêutica, e, método para tratar e/ou prevenir doenças associadas com receptor de adenosina a2a | |
BRPI0510666A (pt) | compostos de amida de arila ou heteroarila de metila substituìda, composições farmacêuticas compreendendo os mesmos, uso e combinação | |
BRPI0606806A2 (pt) | compostos indólicos, suas composições e seus usos | |
BR0307409A (pt) | Compostos de hidrazida de ácido 2-furanocarboxìlico, composições farmacêuticas contendo os mesmos e uso dos mesmos para preparação de um agente preventivo ou terapêutico | |
BRPI0409241A (pt) | compostos bicìclicos como antagonistas do receptor de nr2b, composições farmacêuticas compreendendo os mesmos e seu uso | |
EA200200374A1 (ru) | Производные хинолилпропилпиперидина, их получение и содержащие их композиции | |
BR122017028096B8 (pt) | composto, composição farmacêutica, e, uso do composto | |
BRPI0511532A (pt) | composto, uso do mesmo, composição farmacêutica, e, métodos para a terapia de distúrbios gastrointestinais funcionais e de sìndrome do intestino irritável em um animal de sangue quente, e para a preparação de um composto | |
BRPI0513084A (pt) | antagonistas duplos de nk1/nk3 contra esquizofrenia | |
BRPI0416813A (pt) | compostos de ácido quinolonacarboxìlico com atividade agonista do receptor 5-ht4 | |
MXPA03011638A (es) | Nuevos derivados de 4-piperazinil indol con afinidad por el receptor 5-ht6. | |
BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
BR0210538A (pt) | Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7 | |
BR0009278A (pt) | 1-arenossulfonil-2-aril-pirrolidina e derivados depiperidina | |
BR0011340A (pt) | Composto, processo para preparar o composto, composição, uso de um composto, e, método de tratar doenças alérgicas incluindo a asma brÈnquica, rinite, conjuntivite, dematose e urticária | |
BR0310032A (pt) | Derivados de benzoxazina como moduladores de 5-ht6 e usos dos mesmos | |
NO983493L (no) | Nye benzimidazol-, benzoksazol- og benzotiazolforbindelser, fremgangsmÕte ved fremstilling derav og farmas°ytiske sammensetninger inneholdende slike | |
BR0213026A (pt) | Compostos de imidazopiridina como reguladores do receptor 5-ht4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 4A , 5A , 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010. |